Connect with us

Hi, what are you looking for?

Economy

Asia fast-tracks AstraZeneca rollouts

VIALS with Pfizer-BioNTech, AstraZeneca, Sputnik V, and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken Mar. 19. — REUTERS

TAIPEI/CANBERRA — Many Asian countries are accelerating the rollout of AstraZeneca’s COVID-19 vaccine after confidence in its safety was hit, following reports that the shot was linked to rare blood clots in Europe earlier this month.

After briefly halting its use, many European countries have resumed using the shot in their inoculation programmes after a regional regulator said it was safe, while several country leaders are also taking the vaccine to boost confidence.

The AstraZeneca shot was among the first and cheapest of the COVID-19 vaccines to be developed and launched at volume and is set to be the mainstay of vaccination programmes in much of the developing world.

But its brief suspension raised concerns that a slowdown in vaccination rollouts could hurt the global fight against the pandemic, as coronavirus cases surge in some countries, overwhelming healthcare systems and hurting economies.

“I have just finished getting the (AstraZeneca) injection, there is no pain at the injection site, and there is no soreness of the body,” Taiwan Premier Su Tseng-chang told reporters as the island launched its inoculation campaign on Monday.

Thailand’s prime minister also became the first person in the country to be inoculated with the AstraZeneca vaccine after its rollout was temporarily put on hold over safety concerns, while Indonesia began using it on Monday after suspending it last week. But Indonesia’s Food and Drug agency has warned against its use on people with blood clotting disorders.

South Korean President Moon Jae-in, 68, plans to get the shot on Tuesday after the government said it could be used on older people.

British Prime Minister Boris Johnson received his first dose of the AstraZeneca COVID-19 vaccine on Friday, saying he “did not feel a thing.”

HEADWINDS
The European Medicines Agency regulator said on Thursday the vaccine is effective and not linked with a rise in the overall risk of blood clots.

Yet a survey released on Monday showed that people in seven European countries were more likely to see the vaccine as unsafe than as safe.

Many Asian countries heavily rely on the AstraZeneca vaccine to end the pandemic, as the shot is being used in inoculation programmes in Australia, South Korea, the Philippines, Vietnam, Thailand, and India.

Some countries could face supply issues.

India, which has the highest coronavirus caseload after the United States and Brazil, is delaying supplies of the vaccine to several countries, as it faces a second surge in cases, said a source with direct knowledge of the matter.

The Serum Institute of India (SII), which produces the AstraZeneca vaccine, has told Brazil, Saudi Arabia and Morocco that further supplies will be delayed due to surging demand at home, the person said.

Australia, which has inoculated just 1% of its population so far, is also accelerating vaccination after the country’s pharmaceutical regulator approved on Sunday the local manufacturing of the AstraZeneca vaccine by CSL.

Within 12 weeks, CSL is expected to produce 1 million doses of the vaccine each week. — Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Investing

A cabinet split is hampering the government’s efforts to deal with the nationwide shortage of lorry drivers that threatens fuel supplies at some petrol...

Investing

Pubgoers are flocking back to their locals, according to figures that drew a cautious toast from the industry but also prompted warnings of fresh...

Investing

Ministers are backing a multibillion-pound plan to build another large-scale nuclear power plant in Britain to ease pressure on electricity supplies as the country...

Economy

The Philippines’ balance of payment position (BoP) hit $1.044 billion in August, the highest in four months, due to increased special drawing rights (SDR)...

Economy

Consumers were less pessimistic in the third quarter as more jobs opened up, but business sentiment turned sour amid a fresh surge in coronavirus...

Economy

The Philippine central bank fully awarded the short-term securities it sold at an auction on Friday, even as rates rose on growing inflation fears....

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Economy

US President Joseph R. Biden, Jr., will rely on ally countries to supply the bulk of the metals needed to build electric vehicles and focus on...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.



Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!